Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Dermatology | Family Medicine

Skin Cancer Clinical Trials

A listing of Skin Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 Last 

Alabama

University of South Alabama / Mitchell Cancer Institute SC
Mobile Alabama 36688

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Arizona

University Arizona Cancer Center
Tucson Arizona 85719

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

The University of Arizona Cancer Center
Tucson Arizona 85724

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Arkansas

Highlands Oncology Group SC
Fayetteville Arkansas 72703

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Highlands Oncology Group SC
Fayetteville Arkansas 72753

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

California

Moores UCSD Cancer Center
La Jolla California 92093

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Moores UCSD Cancer Center
La Jolla California 92093

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

University of California, San Francisco
San Francisco California 94115

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

Colorado

AboutSkin Dermatology and DermSurgery
Englewood Colorado 80113

A clinical research study of Dysport (abobotulinumtoxinA) and Bacteriostatic 0.9% Sodium Chloride (vehicle) for the treatment of Scar

Florida

University Cancer Institute SC
Boynton Beach Florida 33426

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Florida Cancer Specialists SC
Fort Myers Florida 33901

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Florida Cancer Specialists Dept of Onc
Fort Myers Florida 33901

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

MSMC Research Program
Miami Beach Florida 33140

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

MSMC Research Program
Miami Beach Florida 33140

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

View More »

Dermatology Associates of Tallahassee
Tallahassee Florida 32308

A clinical study for patients with Melanoma

H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating Panobinostat and Ipilimumab for the treatment of Melanoma or Skin Cancer

H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612

Patients are needed to participate in a clinical research study for the treatment of Metastatic Melanoma

H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612
Updated

Patients are needed to participate in a clinical research study of XL888 and Vemurafenib to evaluate Melanoma

Georgia

Emory University School of Medicine
Atlanta Georgia 30322

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Illinois

Loyola University Medical Center, Div of Hematology/Oncology
Maywood Illinois 60153

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Luther General Cancer Care Institute
Park Ridge Illinois 60068

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Oncology Specialists, SC
Park Ridge Illinois 60068

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Oncology Specialists, SC SC - 5
Park Ridge Illinois 60068-0736

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Indiana

Indiana University Health Goshen Center for Cancer SC
Goshen Indiana 46526

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Indiana University
Indianapolis Indiana 46202

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Iowa

University of Iowa Hospitals and Clinics
Iowa City Iowa 52242

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

University of Iowa Hospitals & Clinics
Iowa City Iowa 52242

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Louisiana

Hematology/Oncology Clinic
Baton Rouge Louisiana 70809

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Maine

Eastern Maine Medical Center Research Center SC
Bangor Maine 04401

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Maryland

The Johns Hopkins University
Baltimore Maryland 21205

A clinical study for patients with Melanoma

Weinberg Cancer Institute at Franklin Square Hospital Dept of Oncology
Baltimore Maryland 21237-3998

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Johns Hopkins Medicine
Lutherville Maryland 21093

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Associates in Oncology/Hematology, P.C. Dept. of Assoc. Onc/Hem
Rockville Maryland 20850

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A clinical study for patients with Melanoma

Brigham and Women's Hospital
Boston Massachusetts 02115

A clinical research study of Cabozantinib for the treatment of Merkel Cell Carcinoma or Skin Cancer

Dana-Farber Cancer Institute
Boston Massachusetts 02215

A clinical research study of Cabozantinib for the treatment of Merkel Cell Carcinoma or Skin Cancer

Massachusetts General Hospital SC -6
Boston Massachusetts 02114

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Michigan

University of Michigan, Comprehensive Cancer Center
Ann Arbor Michigan 48109

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Karmanos Cancer Institute
Detroit Michigan 48201

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Karmanos Cancer Institute
Detroit Michigan 48201

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Wayne State University/Karmanos Cancer Institute SC - 1
Detroit Michigan 48201

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Minnesota

University of Minnesota Masonic Cancer Center
Minneapolis Minnesota 55455

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Missouri

Mercy Medical Research Institute SC-1
Manchester Missouri 63021

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nebraska

Nebraska Cancer Specialists, Midwest Cancer Center - Legacy
Omaha Nebraska 68130

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Nebraska Methodist Hospital Estabrook Cancer Center
Omaha Nebraska 68114

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nevada

Comprehensive Cancer Centers of Nevada CCC of Nevada (1)
Las Vegas Nevada 89109

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

New Hampshire

Dartmouth-Hitchcock Medical Center
Lebanon New Hampshire 03756

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New Jersey

Cooper Cancer Center SC
Camden New Jersey 08103

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

John Theurer Cancer Center at Hackensack University Medical Center
Hackensack New Jersey 07601

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

The Dermatology Group, P.C.
Verona New Jersey 07044

A clinical study for patients with Melanoma

First 1 2 3 4 Last